1994
DOI: 10.1111/j.1440-1827.1994.tb01682.x
|View full text |Cite
|
Sign up to set email alerts
|

Antigen expression associated with lymph node metastasis in gastric adenocarcinomas

Abstract: A total of 100 gastric adenocarcinomas, comprising 50 cases with lymph node metastasis and 50 cases without lymph node metastasis, were examined for immunohistochemical reactivity with the monoclonal antibody to urokinase-type plasminogen activator (u-PA), Lex related 4C9 antigen, Jun, or to nucleobindin (Nuc). In tumors with lymph node metastasis, 41 (82%) were positive for u-PA and 28 (56%) were positive for Nuc. In tumors without lymph node metastasis, 26 (52%) were positive for u-PA and five (10%) were pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
20
0
1

Year Published

1996
1996
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 16 publications
1
20
0
1
Order By: Relevance
“…However, Calnuc was not only well-associated with autoimmune disease, the higher expression of Calnuc was also observed in cancer. For example, a study on gastric adenocarcinoma has demonstrated that in 50 gastric adenocarcinomas with lymph node metastasis, 56% of cases showed a positive reaction to Calnuc, which was much higher compared to that in 50 gastric adenocarcinomas without lymph node metastasis (10%) (30). In another study, Kubota and his colleagues tested the expression of Calnuc in non-Hodgkin's lymphoma by immunohistochemical staining with anti-human Nuc monoclonal antibody; >90% of tumor cells were stained with anti-Nuc, and 65% were in a high grade of histological malignancy, 54% in the intermediate grade and 22% in the low grade (31).…”
Section: Discussionmentioning
confidence: 99%
“…However, Calnuc was not only well-associated with autoimmune disease, the higher expression of Calnuc was also observed in cancer. For example, a study on gastric adenocarcinoma has demonstrated that in 50 gastric adenocarcinomas with lymph node metastasis, 56% of cases showed a positive reaction to Calnuc, which was much higher compared to that in 50 gastric adenocarcinomas without lymph node metastasis (10%) (30). In another study, Kubota and his colleagues tested the expression of Calnuc in non-Hodgkin's lymphoma by immunohistochemical staining with anti-human Nuc monoclonal antibody; >90% of tumor cells were stained with anti-Nuc, and 65% were in a high grade of histological malignancy, 54% in the intermediate grade and 22% in the low grade (31).…”
Section: Discussionmentioning
confidence: 99%
“…The C-terminal (CT) region following the leucine zipper domain is predicted to be intrinsically disordered and unstructured. Intriguingly, NUCB1 is strongly conserved from flies to humans (21) and is widely distributed among Golgi (16,22), nucleus (19,23), endoplasmic reticulum (24,25), and cytoplasm (17). The N-terminal signal sequence of NUCB1 targets it to different membrane compartments and its deletion renders NUCB1 cytosolic.…”
mentioning
confidence: 99%
“…Wang et al studied the antigenic expression of calnuc in gastric adenocarcinomas with lymph-node metastasis by immunohistochemical reactivity studies in patients with and without this tumor (45). It was observed that calnuc was expressed in 56% of patients with lymph-node metastatic tumor when compared with just 10% of patients with tumors not related to lymph node metastasis.…”
Section: Calnuc-related Diseasesmentioning
confidence: 99%